Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus

Brain Research

Volumn 758, Issue 1-2, 1997, Pages 26-32

  Palego, Lionella ^a   Marazziti, Donatella ^a   Rossi, Alessandra ^a   Giannaccini, Gino ^a   Naccarato, Antonio G ^a   Lucacchini, Antonio ^a   Cassano, Giovanni B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

3H 8 OH DPAT; Aging; Gender; Hippocampus; Human brain postmortem; Neocortex; Serotonin 1A receptor

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN; SEROTONIN 1A RECEPTOR;

ADULT; AGED; AGING; ARTICLE; DISSOCIATION CONSTANT; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE; NEOCORTEX; OCCIPITAL CORTEX; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; AGING; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEX CHARACTERISTICS;

EID: 0030742954     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01415-1     Document Type: Article

References (40)

1. L.S. Allen, M. Hines, J.E. Shryne, R.A. Gorsky, Two sexually dimorphic cell groups in the human brain, J. Neurosci. 9 (2) (1989) 497-506.
2. S.J. Allen, J.S. Benton, M.J. Goodhardt, E.A. Haan, N.R. Sims, C.C.T. Smith, J.A. Spillane, D.M. Bowen, A.N. Davison, Biochemical evidence for selective nerve cell changes in the normal ageing human and rat brain, J. Neurochem. 41 (1983) 256-265.
3. 3H]paroxetine binding in rat brain: Effect of imipramine and tetrahydroacridine, Life Sci. 52 (1993) 1767-1775.
4. B. Arranz, A. Eriksson, E. Mellerup, P. Plenge, J. Marcusson, Effect of aging in human cortical pre-and postsynaptic serotonin binding sites, Brain Res. 620 (1993) 163-166.
5. D.B. Blazer, Depression in Late Life, C.V. Mosby Co., St. Louis, 1982, 105 pp.
6. D.M. Bowen, S.J. Allen, J.S. Benton, M.J. Goodhardt, E.A. Haan, A.M. Palmer, N.R. Sims, C.C.T. Smith, J.A. Spillane, M.M. Esilane, D. Neary, J.S. Snowdon, G.K. Wilcock, A.N. Davison, Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease, J. Neurochem. 41 (1983) 266-272.
7. 1 binding sites in depressed suicides, Psychopharmacology 102 (1990) 544-548.
8. C. De Montigny, Y. Chaput and P. Blier, Classical and novel targets for antidepressant drugs, in: J. Mendlewicz, N. Brunello, S.Z. Langer and G. Racagni (Eds.), New Pharmacology Approach to the Therapy of Depressive Disorders, Karger Press, Basel, 1993, pp. 8-28.
9. 1A receptor binding in the human brain postmortem, Brain Res. 554 (1991) 56-64.
10. 3H]PAT, Nature 305 (1983) 140-142.
11. 3H]Imipramine binding in the human brain postmortem, Arch. Gen. Psychiatry 46 (1989) 237-242.
12. 2 receptors in the human brain postmortem, Brain Res. 519 (1990) 223-227.
13. B. Gurland, L. Dean, P. Cross and B. Golden, Age and affective disorders, in: J.O. Cole (Ed.), Psychopathology in the Aged, Raven Press, New York, 1980, 37 pp.
14. M. Hamon, S. Bourguin, H. Gozlan, M.D. Hall, C. Goetz, F. Artaud, A.S. Horn, Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-N-propylamino)tetralin) in the rat brain, Eur. J. Pharmacol. 100 (1984) 263-276.
15. 1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia, Life Sci. 48 (1991) 355-363.
16. 1B recognition sites, Brain Res. 376 (1986) 85-96.
17. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, P.A. Humphrey, International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol. Rev. 46 (1994) 157-203.
18. B. Kirkpatrick, N.L. Bryant, Sexual dimorphism in the brain: It's worse than you thought, Biol. Psychiatry 38 (1995) 347-348.
19. P. Lepage and M. Steiner, Gender and serotonergic dysregulation: Implications for late luteal phase dysphoric disorders, in: G.B. Cassano and H.S. Akiskal (Eds.), Serotonin-Related Psychiatric Syndromes: Clinical and Therapeutical Links, Royal Society of Medicine Services Ltd., London/New York, 1991, pp. 131-143.
20. 1A) receptor-mediated hypothermie response to ipsapirone in unipolar depression, Life Sci. 46 (1990) 1271-1277.
21. I. Lucki, S. Wieland, 5-Hydroxytryptamine receptors and behavioral responses, Neuropsychopharmacology 3 (1990) 481-493.
22. McPherson, G.A., KINETIC, EBDA, LIGAND, LOWRY: A collection of radioligand binding analysis programs, Biosoft, Cambridge, UK, 1985.
23. 1A) receptors in human brain postmortem, Brain Res. 658 (1994) 55-59.
24. J. Marcusson, L. Oreland, B. Winblad, Effect of age on serotonin (S-1) binding sites, J. Neurochem. 43 (1984) 1699-1705.
25. D.N. Middlemiss, A.N. Palmer, N. Edel, D.W. Bowen, Binding of the novel serotonin agonist 8-hydroxy-2-(di-N-propylamino)tetralin in normal and Alzheimer brain, J. Neurochem. 46 (1986) 993-996.
26. D.G. Morgan, The dopamine and serotonin systems during aging in human and rodent brain. A brief review, Prog. Neuropsychopharmacol. Biol. Psychiatr. 11 (1987) 153-157.
27. D.L. Murphy, Neuropsychiatrie disorders and the multiple human brain 5-HT receptor subtypes and subsystems, Neuropharmacology 3 (1990) 457-471.
28. C. O'Neill, R.F. Cowbun, B. Wiehager, I. Alafuzoff, B. Windbland, C.J. Fowler, Preservation of 5-hydroxytryptamine-1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease, Neurosci. Lett. 133 (1991) 15-19.
29. N.N. Osborne and M. Hamon, Neuronal Serotonin, Wiley, Chich-ester, 1988.
30. 3H]8-Hydroxy-2-(di-N-pro-pylamino)tetralin binding sites in human brain postmortem, Neurochem. Int. (in press).
31. 1c binding sites in rat frontal cortex, J. Neurochem. 47 (1986) 529-540.
32. G.L. Peterson, A simplification of the protein assay method which is more generally applicable, Anal. Biochem. 83 (1987) 356-366.
33. S.N. Pradhan, Central neurotransmitters and aging, Life Sci. 26 (1980) 1643-1656.
34. F. Saudou, R. Hen, 5-hydroxytryptamine receptor subtypes in vertebrates and invertebrates, Neurochem. Int. 25 (1994) 503-532.
35. 1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms, Prog. Neuropsychopharmacol. Biol. Psychiatry 17 (1) (1993) 87-104.
36. L.D. Van der Kar, Neuroendocrine pharmacology of serotonergic (5-HT) neurons, Annu. Rev. Pharmacol. Toxicol. 31 (1991) 289-320.
37. M.M. Weissmann, Affective disorders, in: L.N. Robins and D.A. Regier (Eds.), Psychiatric Disorders in America, The Epidemiologic Catchment Area Study, Free Press, New York, 1991, pp. 53-80.
38. 1 receptors mediate inhibition of cyclic AMP production in neurons, Eur. J. Pharmacol. 120 (1986) 227-230.
39. D.F. Wong, H.N. Wagner Jr., R.F. Dannals, J.M. Links, J.J. Frost, H.T. Ravert, A.A. Wilson, A.E. Rosenbaum, A. Gjedde, K.H. Douglass, J.D. Petronis, M.F. Folstein, J.K.T. Toung, H.D. Burns, M.J. Kuhar, Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain, Science 226 (1984) 1393-1396.
40. R. Yamamoto, A. Hirano, Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons, Ann. Neurol. 17 (1985) 573-577.